Interactive Transcript
0:01
So the next thing we tend to see on our
0:03
diagnostic service is the patient who
0:05
is following up after a benign biopsy.
0:09
And our protocol, we recognize that
0:13
different practices practice differently.
0:15
Our Hopkins protocol is to follow up with a
0:17
diagnostic evaluation in one year and then
0:20
return to screening if everything looks fine.
0:24
We usually follow up with the
0:25
modality that was used for biopsy.
0:27
So if it was an ultrasound-guided
0:29
biopsy, we'll do ultrasound for follow-up
0:32
was a mammogram-guided biopsy.
0:34
We use mammogram to follow.
0:36
And it's interesting to note that the literature
0:39
really does not advise six-month diagnostic
0:43
follow-up after benign biopsy, unless there's
0:45
a separate BI-RADS three finding for follow-up.
0:47
So sometimes we might have.
0:50
You know, two masses.
0:51
We biopsied one.
0:52
It was benign.
0:53
The other one is similar, appearing maybe
0:55
slightly smaller, and we're recommending
0:57
that for follow-up on the BI-RADS 3 pathway.
1:02
Or maybe there are multiple
1:03
similar groups of calcifications.
1:05
The most concerning one was biopsied and found
1:08
to be benign, and we're following the other.
1:10
Um, calcifications, that would be a reason
1:12
to do a six-month follow-up, but we don't
1:14
routinely do a six-month follow-up biopsy.
1:17
And there's some references here at the
1:19
bottom of the slide discussing the lack of
1:23
utility of six-month follow-up as a routine.
1:27
We also know that some practices go right
1:30
back to screening after a benign biopsy
1:32
and don't do any specific follow-up.
1:35
Um, I think that's, you know,
1:37
a little bit challenging, especially
1:38
for ultrasound-guided biopsies.
1:41
You know, if a mass is surrounded by
1:43
relatively dense tissue, we may not be able
1:45
to assess its size on a routine screening.
1:48
So we typically will do the
1:51
diagnostic evaluation one year later.
© 2024 MRI Online. All Rights Reserved.